Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upadacitinib in Pediatric Non-Segmental Vitiligo
NCT07896434Phase 3Not yet recruiting
- Sponsor
- AbbVie Inc.
- Start
- Jan 2027
- Primary completion
- Aug 2032
01
Overview
A Phase 3 trial of upadacitinib in Vitiligo, sponsored by AbbVie Inc.. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
upadacitinib
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT07896434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07896434.